Jade Biosciences (JBIO) Non Operating Income (2020 - 2026)
Jade Biosciences (JBIO) posted Non Operating Income of $3.1 million for Q1 2026, little changed on a QoQ basis from $3.1 million in Q4 2025, and up 120.92% year-over-year from $1.4 million in Q1 2025.
Jade Biosciences (JBIO) Non Operating Income (2020 - 2026) Analysis & Trends
Jade Biosciences' Non Operating Income history runs 7 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- Quarterly Non Operating Income rose 120.92% year-over-year to $3.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.1 million (up 116.64% YoY) and the FY2025 annual result came in at -$13.8 million, down 374.94% from the prior year.
- Non Operating Income was $3.1 million for Q1 2026 at Jade Biosciences, roughly flat from $3.1 million in the prior quarter.
- Across five years, Non Operating Income topped out at $3.1 million in Q4 2025 and bottomed at -$14.8 million in Q1 2025.
- A 5-year average of -$656705.9 and a median of $1.1 million in 2023 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2022 — Non Operating Income soared 11400.0% — and 2025, when it sank 1132.47%.
- Jade Biosciences' Non Operating Income stood at $934000.0 in 2022, then jumped by 82.98% to $1.7 million in 2023, then slumped by 769.46% to -$11.4 million in 2024, then soared by 127.14% to $3.1 million in 2025, then retreated by 0.39% to $3.1 million in 2026.
- Business Quant data shows JBIO's Non Operating Income at $3.1 million in Q1 2026, $3.1 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -8.59 Mn |
| 10 | Jade Biosciences | 16.25 Mn | 16.25 Mn | - | 3.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.09 Mn |
| Dec 31, 2025 | 3.11 Mn |
| Sep 30, 2025 | 2.23 Mn |
| Jun 30, 2025 | -4.36 Mn |
| Mar 31, 2025 | -14.79 Mn |
| Dec 31, 2024 | -11.44 Mn |
| Sep 30, 2024 | 388,000.00 |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 934,000.00 |
| Sep 30, 2022 | 560,000.00 |
| Jun 30, 2022 | 230,000.00 |
| Mar 31, 2022 | 109,000.00 |
| Dec 31, 2021 | 51,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 2,000.00 |